Market Tracker

08/01 6:05pm ET

Haemonetics Corp (NYSE:HAE)

34.98
Data as of Aug 01
 -0.59 / -1.66%
Today’s Change
29.86
Today|||52-Week Range
44.20
-16.97%
Year-to-Date

Today’s Trading

Previous close35.57
Today’s open35.61
Day’s range34.64 - 35.75
Volume295,181
Average volume (3 months)356,577
Market cap$1.8B
Dividend yield--
Data as of 4:01pm ET, 08/01/2014

Growth & Valuation

Earnings growth (last year)-9.46%
Earnings growth (this year)-13.82%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+5.22%
P/E ratio52.2
Price/Sales1.77
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
NUVANuVasive Inc-0.05-0.13%
PODDInsulet Corp-0.98-2.77%
GMEDGlobus Medical Inc-0.11-0.49%
IARTIntegra LifeSciences...-0.18-0.38%
Data as of 4:06pm ET, 08/01/2014

Financials

Last reporting dateJuly 30, 2014
EPS forecast (this quarter)$0.36
Annual revenue (last year)$938.5M
Annual profit (last year)$35.1M
Net profit margin3.75%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Brian P. Concannon
Chief Financial Officer &
EVP-Business Development
Christopher J. Lindop
Corporate headquarters
Braintree, Massachusetts

Forecasts